Potent α-glucosidase and α-amylase inhibitory activities of standardized 50% ethanolic extracts and sinensetin from Orthosiphon stamineus Benth as anti-diabetic mechanism

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Mohamed, Elsnoussi Ali H ^a   Siddiqui, Mohammad Jamshed A ^b   Ang, Lee F ^a   Sadikun, Amirin ^a   Chan, Sue H ^a   Tan, Soo C ^a   Asmawi, Mohd Z ^a   Yam, Mun F ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; AMYLASE; AMYLASE INHIBITOR; ANTIDIABETIC AGENT; ORTHOSIPHON STAMINEUS EXTRACT; PLANT EXTRACT; SINENSETIN; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; ENZYME INHIBITION; IC 50; NUCLEAR MAGNETIC RESONANCE;

ALPHA-AMYLASES; ALPHA-GLUCOSIDASES; DIABETES MELLITUS, TYPE 2; ENZYME INHIBITORS; HUMANS; HYPOGLYCEMIC AGENTS; ORTHOSIPHON; PLANT EXTRACTS;

EID: 84867053639     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-176     Document Type: Article

References (30)

1. Harrower AD. Comparison of efficacy, secondary failure rate, and complications of sulfonylureas. J Diabetes Complications 1994, 8:201-203. 10.1016/1056-8727(94)90044-2, 7833494.
2. Reuser AJ, Wisselaar HA. An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus. Eur J Clin Invest 1994, 24:19-24.
3. Campbell RK, White JR, Saulie BA. Metformin: a new oral biguanide. Clin Ther 1996, 18:360-371. 10.1016/S0149-2918(96)80017-8, 8829014.
4. Kwon YI, Apostolidis E, Shetty K. Inhibitory potential of wine and tea against α-amylase and α-glucosidase for management of hyperglycemia linked to type 2 diabetes. J Food Biochem 2008, 32:15-31.
5. Gray GM. Carbohydrate digestion and absorption-role of small intestine. N Engl J Med 1975, 292:1225-1230. 10.1056/NEJM197506052922308, 1093023.
6. Krentz AJ, Baile CJ. Oral antidiabetic agents: Current role in type 2 diabetes mellitus. Drugs 2005, 65:385-411. 10.2165/00003495-200565030-00005, 15669880.
7. Jaganath L, Ng LT. Herbs: The green pharmacy of Malaysia 2000, 76-77. Kuala Lumpur: Vinpress Sdn. Bhd.
8. Awale S, Tezuka Y, Banskota AH, Adnyana IK, Kadota S. Nitric oxide inhibitory isopimarane-type diterpenes from Orthosiphon stamineus of Indonesia. J Nat Prod 2003, 66:255-258. 10.1021/np020455x, 12608860.
9. Awale S, Tezuka Y, Banskota AH, Kadota S. Highly-oxygenated isopimarane-type diterpenes from Orthosiphon stamineus of Indonesia and their nitric oxide inhibitory activity. Chem Pharm Bull 2003, 26:268-275.
10. Malterud KE, Hanche-Olsen IM, Smith-Kelland I. Flavonoids from Orthosiphon spicatus. Planta Med 1989, 55:569-570. 10.1055/s-2006-962099, 2616675.
11. Sumaryono W, Proksch P, Wray V, Witte L, Hartmann T. Qualitative and quantitative analysis of the phenolic constituents from Orthosiphon aristatus. Planta Med 1991, 57:176-180. 10.1055/s-2006-960060, 17226146.
12. Masuda T, Masuda K, Shiragami S, Jitoe A, Nakatani N. Orthosiphols A and B, novel diterpenoid inhibitors of TPA (12-O-tetradecanoylphorbol-13-acetate)-induced inflammation, from Orthosiphon stamineus. Tetrahedron 1992, 48:6787-6792.
13. Tezuka Y, Stampoulis P, Banskota AH, Awale S, Tran KQ, Saiki I, Kadota S. Constituents of the Vietnamese medicinal plant Orthosiphon stamineus. Chem Pharm Bull 2000, 48:1711-1719. 10.1248/cpb.48.1711, 11086900.
14. Olah NK, Radu L, Mogoşan C, Hanganu D, Gocan S. Phytochemical and pharmacological studies on Orthosiphon stamineus Benth. (Lamiaceae) hydroalcoholic extracts. J Pharm Biomed Anal 2003, 33:117-123. 10.1016/S0731-7085(03)00227-9, 12946538.
15. Mohamed EA, Mohamed AJ, Asmawi MZ, Sadikun A, Ebrika OS, Yam MF. Antihyperglycemic Effect of Orthosiphon Stamineus benth leaves extract and its bioassay-guided fractions. Molecules 2011, 16:3787-3801. 10.3390/molecules16053787, 21544041.
16. Yam MF, Asmawi MZ, Basir R. An Investigation of the anti-inflammatory and analgesic effects of Orthosiphon stamineus leaf extract. J Med Food 2008, 11:362-368. 10.1089/jmf.2006.065, 18598181.
17. Yam MF, Ang LF, Salman IM, Ameer OZ, Lim V, Ong LM, Ahmad M, Asmawi MZ, Basir R. Orthosiphon stamineus leaf extract protects against ethanol-induced gastropathy in rats. J Med Food 2009, 12:1089-1097. 10.1089/jmf.2008.0005, 19857074.
18. Yam MF, Mohamed EAH, Ang LF, Pei L, Darwis Y, Mahmud R, Asmawi MZ, Basir R, Ahmad M. A simple isocratic HPLC method for the simultaneous determination of sinensetin, eupatorin, and 3′-hydroxy-5,6,7,4′-tetramethoxyflavone in Orthosiphon stamineus extracts. J Acupunct Meridian Stud 2012, 5:176-182. 10.1016/j.jams.2012.05.005, 22898066.
19. Yam MF, Lim V, Salman IM, Ameer OZ, Ang LF, Rosidah N, Abdulkarim MF, Abdullah GZ, Basir R, Sadikun A, Asmawi MZ. HPLC and anti-inflammatory studies of the flavonoid rich chloroform extract fraction of Orthosiphon stamineus leaves. Molecules 2010, 15:4452-4466. 10.3390/molecules15064452, 20657453.
20. Apostolidis E, Kwon Y, Shetty K. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innovative Food Science and Emerging Technologies 2007, 8:46-54.
21. Young-In K, Emmanouil A, Kalids S. Inhibitory potential of wine and tea against α-amylase and α-glucosidase for management of hyperglycemia linked to type 2 diabetes. J Food Biochem 2008, 32:15-31.
22. World Health Organisation Consultation Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus 1999, Geneva: Report of WHO Consultation, World Health Organisation Consultation.
23. Rhabasa-Lhoret R, Chiasson JL. α-Glucosidase inhibitors. International Textbook of Diabetes Mellitus, vol. 1 2004, 901-914. U.K: John Wiley & Sons Ltd, Defronzo RA, Ferrannini E, Keen H, Zimmet P, 3.
24. Bailey CJ. New approaches to the pharmacotherapy of diabetes. Textbook of Diabetes, vol. 2 2003, 73.1-73.21. U.K: Blackwell Science Ltd, Pickup JC, William G, 3.
25. Joubert PH, Venter HL, Foukaridis GN. The effect of miglitol and acarbose after an oral glucose load: A novel hypoglycaemic mechanism. Br J Clin Pharmacol 1990, 30:391-396. 10.1111/j.1365-2125.1990.tb03789.x, 1368141, 2223417.
26. Mariam A, Asmawi MZ, Sadikun A. Hypoglycaemic activity of the aqueous extract of Orthosiphon stamineus. Fitoterapia 1996, 67:465-468.
27. Sriplang K, Adisakwattana S, Rungsipipat A, Yibchok-Anun S. Effects of Orthosiphon stamineus aqueous extract on plasma glucose concentration and lipid profile in normal and streptozotocin-induced diabetic rats. J Ethnopharmacol 2007, 109:510-514. 10.1016/j.jep.2006.08.027, 17034971.
28. Cheng JT, Liu IM. Stimulatory effect of caffeic acid on alpha 1 Aadrenoceptors to increase glucose uptake into cultured C2C12 cells. Naunyn Schmiedebergs Arch Pharmacol 2000, 362:122-127. 10.1007/s002100000274, 10961374.
29. Tadera K, Minami Y, Takamatsu K, Matsuoka T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J Nutr Sci Vitaminol 2006, 52:149-153. 10.3177/jnsv.52.149, 16802696.
30. Kwon YI, Apostolidis E, Shetty K. In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Bioresour Technol 2008, 99:2981-2988. 10.1016/j.biortech.2007.06.035, 17706416.